These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 31498430)
1. Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer. Ren F; Zhao Q; Liu B; Sun X; Tang Y; Huang H; Mei L; Yu Y; Mo H; Dong H; Zheng P; Mi Y J Cell Physiol; 2020 Mar; 235(3):2738-2752. PubMed ID: 31498430 [TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
3. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment. Yao K; Wei L; Zhang J; Wang C; Wang C; Qin C; Li S Aging (Albany NY); 2020 Aug; 12(16):16238-16254. PubMed ID: 32833670 [TBL] [Abstract][Full Text] [Related]
4. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus. Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma. Wu X; Wang S; Wang C; Wu C; Zhao Z Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086 [TBL] [Abstract][Full Text] [Related]
6. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway. Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278 [TBL] [Abstract][Full Text] [Related]
7. Identification of Immune Infiltrating Cell-Related Biomarkers in Early Gastric Cancer Progression. Ji C; Cai H; Jin X; Yin K; Zhao D; Feng Z; Liu L Technol Cancer Res Treat; 2024; 23():15330338241262724. PubMed ID: 38860335 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB. Zhao H; Xu J; Wang Y; Jiang R; Li X; Zhang L; Che Y Surg Oncol; 2018 Sep; 27(3):495-502. PubMed ID: 30217308 [TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
10. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974 [TBL] [Abstract][Full Text] [Related]
11. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses. Wan Z; Zhang X; Luo Y; Zhao B Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428 [No Abstract] [Full Text] [Related]
12. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map. Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111 [TBL] [Abstract][Full Text] [Related]
13. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma. Zhou LN; Li SC; Li XY; Ge H; Li HM Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838 [TBL] [Abstract][Full Text] [Related]
14. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
15. Identifying Diagnostic and Prognostic Differentially Expressed Genes of Gastric Cancer Based on Bioinformatics Analyses of RNA-seq Data. Wang M; Jiang X; Xu S; Deng Y; Cao T; Cheng Y; Zhang WH; Zhang L; Hu J Genet Test Mol Biomarkers; 2022 Nov; 26(11):512-521. PubMed ID: 36383109 [No Abstract] [Full Text] [Related]
16. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus. Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707 [TBL] [Abstract][Full Text] [Related]
17. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics. Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344 [No Abstract] [Full Text] [Related]
18. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489 [TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway. Yang W; Xie T Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405 [TBL] [Abstract][Full Text] [Related]
20. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis. Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]